Projects per year
Fingerprint Dive into the research topics where Paul F. Riska is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Mycobacterium tuberculosis
Medicine & Life Sciences
Luciferases
Medicine & Life Sciences
Mycobacteriophages
Medicine & Life Sciences
Bacteriophages
Medicine & Life Sciences
Clostridium difficile
Medicine & Life Sciences
Clostridium Infections
Medicine & Life Sciences
Mycobacterium
Medicine & Life Sciences
Anti-Bacterial Agents
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 1998 2004
- 1 Finished
Mycobacterium
Tuberculosis
Bacteriophages
Molecular Biology
Mycobacteriophages
Publications 1989 2018
8
Citations
(Scopus)
Effect of algorithm-based therapy vs usual care on clinical success and serious adverse events in patients with staphylococcal bacteremia a randomized clinical trial
the Staphylococcal Bacteremia Investigators, Sep 25 2018, In : JAMA - Journal of the American Medical Association. 320, 12, p. 1249-1258 10 p.Research output: Contribution to journal › Article
Bacteremia
Randomized Controlled Trials
Therapeutics
Anti-Bacterial Agents
Coagulase
Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study
For the INSIGHT FLU003 Plus Study Group, Jan 1 2018, In : Open Forum Infectious Diseases. 5, 1, ofx228.Research output: Contribution to journal › Article
Indoleamine-Pyrrole 2,3,-Dioxygenase
Human Influenza
Disease Progression
Tryptophan
Kynurenine
Two for the price of one: Emerging carbapenemases in a returning traveller to New York City
Mittal, J., Szymczak, W. A., Guo, Y., Levi, M. H., Chen, L., Kreiswirth, B. N., Riska, P. F. & Nori, P., Jan 1 2018, In : BMJ Case Reports. 2018, bcr-2018-225440.Research output: Contribution to journal › Article
Carbapenems
Bangladesh
Enterobacteriaceae Infections
Aztreonam
Klebsiella pneumoniae
36
Citations
(Scopus)
Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study
CoDIFy study group, Jul 1 2017, In : The Lancet Infectious Diseases. 17, 7, p. 735-744 10 p.Research output: Contribution to journal › Article
Clostridium Infections
Clostridium difficile
Vancomycin
Safety
Therapeutics
8
Citations
(Scopus)
INSIGHT FLU005: An anti-influenza virus hyperimmune intravenous immunoglobulin pilot study
Davey, R. T., Markowitz, N., Beigel, J., Wentworth, D., Babiker, A., Rehman, T., Dewar, R., Metcalf, J., Uyeki, T. M., Finley, E. B., Standridge, B., Riska, P. F., Lane, H. C., Gordin, F., Neaton, J. D., Denning, E., Duchene, A., Engen, N., Harrison, M., Quan, K. & 27 others, , Feb 15 2016, In : Journal of Infectious Diseases. 213, 4, p. 574-578 5 p.Research output: Contribution to journal › Article
Intravenous Immunoglobulins
Orthomyxoviridae
Human Influenza
Confidence Intervals
Hemagglutination